Pharmacoeconomics is an important part of the postmarketing Chinese medicine （CM） evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing...Pharmacoeconomics is an important part of the postmarketing Chinese medicine （CM） evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair. Every country＇s guidelines for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the guideline that takes into account the special characteristics of CM; and these are in preparation for the postmarketing CM pharmacoeconomic evaluation.展开更多
基金Supported by Research on Key Techniques of Reevaluation of Postmarketing Chinese Medicines,the Ministry of Science and Technology(No.2009ZX09502-030)the Seventh-Science Foundation of China Academy of Chinese Medical Sciences(No.ZZ070817)National Natural Science Foundation of China(General program,No.81202776)
文摘Pharmacoeconomics is an important part of the postmarketing Chinese medicine （CM） evaluation, and postmarketing pharmacoeconomic evaluation can reveal the clinical and market value of CM. The purpose of establishing the guideline for pharmacoeconomic evaluation is to make the evaluation process and results regarding Chinese patent medicines both scientific and fair. Every country＇s guidelines for pharmacoeconomic evaluation act as reference guidelines, we have already drawn up the guideline that takes into account the special characteristics of CM; and these are in preparation for the postmarketing CM pharmacoeconomic evaluation.
